22041-23-2

Basic information

• Product Name: ETHYL 4-(DIMETHYLAMINO)BUTANOATE
• Synonyms: ETHYL 4-(DIMETHYLAMINO)BUTANOATE;4-(Dimethylamino)butyric acid ethyl ester;Butanoic acid, 4-(diMethylaMino)-, ethyl ester
• CAS NO: 22041-23-2
• Molecular Formula: C₈H₁₇NO₂
• Molecular Weight: 159.23
• Mol File: 22041-23-2.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 194.7°C at 760 mmHg
• Flash Point: 65.8°C
• Appearance: /
• Density: 0.929g/cm³
• Vapor Pressure: 0.436mmHg at 25°C
• Refractive Index: 1.433
• PKA: 9.40±0.28(Predicted)
• CAS DataBase Reference: ETHYL 4-(DIMETHYLAMINO)BUTANOATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 4-(DIMETHYLAMINO)BUTANOATE(22041-23-2)
• EPA Substance Registry System: ETHYL 4-(DIMETHYLAMINO)BUTANOATE(22041-23-2)

Safety Data

• Hazardous Substances Data: 22041-23-2(Hazardous Substances Data)

Usage

General Description

ETHYL 4-(DIMETHYLAMINO)BUTANOATE is a chemical compound with the molecular formula C8H17NO2. It is a clear, colorless liquid with a fruity odor, commonly used in the production of flavors and fragrances. ETHYL 4-(DIMETHYLAMINO)BUTANOATE is commonly found in various food and cosmetic products as a flavoring agent. It is also used in the synthesis of pharmaceuticals and as an intermediate in organic synthesis. ETHYL 4-(DIMETHYLAMINO)BUTANOATE is known for its mild anesthetic effects and is used in some topical anesthetic products. It is important to handle this chemical with caution and follow proper safety protocols due to its potential health hazards.

InChI:InChI=1/C8H17NO2/c1-4-11-8(10)6-5-7-9(2)3/h4-7H2,1-3H3

Upstream product

• 5429-29-8 1,3-diethyl 2-[2-(dimethylamino)ethyl]propanedioate 
• 64-17-5 ethanol 
• 693-11-8 4-dimethylamino-butyric acid 
• 2969-81-5 Ethyl 4-bromobutyrate 
• 124-40-3 dimethyl amine 

Downstream Products

• 13330-96-6 4-dimethylamino-1-butanol 
• 5471-47-6 γ-Dimethylaminobutyrohydrazid 
• 1357620-05-3 benzyl 4-(4-(dimethylamino)butanamido)benzoate 
• 1357620-07-5 benzyl 3-(4-(dimethylamino)butanamido)benzoate 
• 751479-06-8 4-(4-(dimethylamino)butanamido)benzoic acid 
• 1357620-10-0 3-(4-(dimethylamino)butanamido)benzoic acid 
• 69954-66-1 4-(dimethylamino)butyric acid hydrochloride 
• 1580507-02-3 N-benzyl-4-ethoxy-N,N-dimethyl-4-oxobutan-1-aminium bromide 
• 1580507-20-5 4-(benzyldimethylammonio)butanoate 

Relevant articles and documents

Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs

Ephrin A2 targeted immunoliposomes incorporating pH-sensitive taxane prodrugs were developed for sustained delivery of active drug to solid tumors. Here we describe the systematic formulation development and characterization of these immunoliposomes. We s

Targeting carnitine biosynthesis: Discovery of new inhibitors against γ-butyrobetaine hydroxylase

γ-Butyrobetaine hydroxylase (BBOX) catalyzes the conversion of gamma butyrobetaine (GBB) to l-carnitine, which is involved in the generation of metabolic energy from long-chain fatty acids. BBOX inhibitor 3-(1,1,1-trimethylhydrazin-1-ium-2-yl)propanoate (

4-[(HALOALKYL)(DIMETHYL)AMMONIO]BUTANOATES AND USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR DISEASE

4-[(Haloalkyl)(dimethyl)ammonio]butanoates of formula (I) wherein Hal is Cl or F, n=1 or 2, method for preparing thereof and use thereof for treating cardiovascular disease.